Howard Federoff, UC Irvine, to speak at the GTCbio's Metabolomics Conference

Howard Federoff, UC Irvine, to speak at the GTCbio's 3rd Metabolomics - Advances & Applications in Human Disease Conference. End Quote

(1888PressRelease) April 02, 2016 - GTCbio is proud to present the 3rd Metabolomics - Advances & Applications in Human Disease Conference, which will be part of The Genomics & Big Data Summit and takes place May 25-26, 2016 in Boston, MA.

Register for this event to hear from keynote Howard Federoff, University of California, Irvine.

Howard is currently the Vice Chancellor of Health Affairs, the Dean of the School of Medicine, and acting CEO of UCI Health at the University of California, Irvine.

Prior to joining UCI, Howard served as the Executive Vice President for Health Sciences at Georgetown University and Executive Dean of the School of Medicine, Dr. Federoff was responsible for Georgetown University Medical Center (GUMC). He was a professor of Neurology and Neuroscience.

Prior to Georgetown, he held appointments as Senior Associate Dean; Professor of Neurology, Medicine, Microbiology and Immunology; and Professor of Oncology and Genetics at the University of Rochester School of Medicine, and as Founding Director of the Center for Aging and Development Biology at the Aab Institute of Biomedical Sciences and Founding Division Chief of Molecular Medicine and Gene Therapy. He also served as Director of the University of Rochester's Interdepartmental Neuroscience Program.

Dr. Federoff's research interests include gene therapy and neurodegenerative diseases. He has published greater than 250 peer review and invited articles and serves as a reviewer for many journals, and currently serves on the editorial boards of the Journal of Parkinson's Disease, Open Genomics Journal and Journal of Experimental Neurology. Dr. Federoff served as Chair of the NIH Recombinant DNA Advisory Committee from 2007-2010. He Chairs the Gene Therapy Resource Program for NHLBI, was President of the American Society for Neural Therapy and Repair (2012-2013) and is President of the American Society for Experimental Neurotherapeutics. Dr. Federoff received MS, PhD, and MD degrees from the Albert Einstein College of Medicine, did his internship, residency, and clinical and research fellowships at Massachusetts General Hospital/Harvard Medical School, and practiced medicine at the Albert Einstein College of Medicine and University of Rochester. He is a Fellow of the AAAS and National Academy of Inventors.

Attend the 3rd Metabolomics - Advances & Applications in Human Disease Conference to listen to Howard Federoff's keynote talk and network with colleagues from industry and academia and discuss the most recent advances in metabolomics.

This conference is part of the Genomics & Big Data Summit and features the following four tracks:
6th Next Generation Sequencing
3rd Metabolomics-Advances & Applications in Human Disease
CRISPR & Genome Engineering
Big Data Bioinformatics

For more information, please visit www.gtcbio.com/metabolomics or contact us using the information below.

GTCbio
635 W. Foothill Blvd
Monrovia, CA 91016
www.gtcbio.com/
Email: infogtcbio ( @ ) gtcbio dot com
Phone: (626) 256-6405
Fax: (626) 466-4433

###

space

Other Related Press Releases